Novo signs deal with Swedish firm Nanexa worth up to 8.7 billion kroner
Danish pharma giant Novo has signed a licensing agreement worth up to 8.7 billion Danish kroner with Swedish company Nanexa.
2026年9月25日
/ DANGDI / DANGDI / DANGDI /Danish company Novo has agreed a deal with Swedish firm Nanexa. The deal is worth up to 8.7 billion Danish kroner. This shows strong business links between Denmark and Sweden. The agreement focuses on pharmaceutical technology.
Nanexa said the deal includes upfront and milestone payments. These early payments total about 4.6 billion Danish kroner. Nanexa may also get royalties if products reach the market. These royalties would be in the low single-digit percentage range. The Copenhagen Post reported this new cross-border deal.
Source: The Copenhagen Post
